Centro de Oncología de Precisión (COP)
Colecciones en esta comunidad
-
Papers publicados por COP
Contiene los artículos/papers publicados en revistas nacionales e internacionales
Envíos recientes
-
Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population
(MDPI, 2023-02)Breast cancer (BC) is the most common cancer among women worldwide. BRCA1/2 are responsible for 16-20% of the risk for hereditary BC. Other susceptibility genes have been identified; Fanconi Anemia Complementation Group M ... -
Corrigendum: Unraveling patient heterogeneity in complex diseases through individualized co-expression networks: a perspective (vol 14, 1209416, 2023)
(FRONTIERS MEDIA SA, 2023-09-21)Sin resumen. -
Unraveling patient heterogeneity in complex diseases through individualized co-expression networks: a perspective
(FRONTIERS MEDIA SA, 2023-08-10)This perspective highlights the potential of individualized networks as a novel strategy for studying complex diseases through patient stratification, enabling advancements in precision medicine. We emphasize the impact ... -
Aging Hallmarks and the Role of Oxidative Stress
(MDPI, 2023-03)Aging is a complex biological process accompanied by a progressive decline in the physical function of the organism and an increased risk of age-related chronic diseases such as cardiovascular diseases, cancer, and ... -
Genome sequencing reveals molecular subgroups in oral epithelial dysplasia
(SOCIEDADE BRASILEIRA DE PESQUISA ODONTOLOGICA, 2023-07-16)This study aimed to analyze the molecular characteristics of oral epithelial dysplasia (OED), highlighting the pathways and variants of genes that are frequently mutated in oral squamous cell carcinoma (OSCC) and other ... -
Planificación sanitaria a partir de los datos ómicos: ¿es posible esta idea para Chile?
(Chile. Universidad Mayor, 2021-11)With or without a COVID19 pandemic, cancer is and will continue to be one of the greatest health challenges on the planet. In Chile, during 2016, this disease was the second cause of death in the country and during 2019, ... -
La inhibición de los puntos de control inmunológico, una terapia en evolución: remembranza del Premio Nobel de Medicina 2018
(Chile. Universidad Mayor, 2022-01)Professors James P. Allison and Tasuku Honjo were awarded with the 2018 Nobel Prize in Medicine for their contributions in cancer immunotherapy. The latter is a breakthrough in cancer therapy, aimed to overcome tumor-induced ...